#USA #Securities Laws #DJS Law Group #Eastchester #Immutep Limited

Immutep Limited Sued for Securities Law Violations

In a significant development for investors, Immutep Limited has come under fire with a class action lawsuit alleging violations of the Securities Exchange Act of 1934. The suit, initiated by the DJS Law Group, highlights critical concerns regarding the company’s disclosure practices and the transparency of its communications with shareholders.

Background of the Case

The lawsuit targets Immutep Limited, a company traded on NASDAQ under the ticker symbol IMMP. The class period defined for the lawsuit spans from March 24, 2025, to March 12, 2026. Investors who purchased shares of IMMP during this timeframe are strongly urged to come forward and seek potential representation in the ongoing case.

Allegations

The crux of the allegations lies in claims that Immutep made misleading statements about its clinical trial, specifically the TACTI-004 trial of its product eftilagimod alfa (commonly referred to as “efti”). According to the complaint, Immutep allegedly stated on January 30, 2026, that the trial was demonstrating significant operational progress. However, subsequent revelations indicated that the company was aware that the trial was not on track to meet its primary efficacy endpoints. This contradiction raises serious questions about the trustworthiness of Immutep's communications during the class period.

Implications for Investors

Shareholders who feel they were adversely affected by these misleading statements are encouraged to participate in the lawsuit. Notably, appointment as a lead plaintiff is not a requirement for individuals wishing to seek recovery under the terms of the lawsuit. The deadline for filing claims is set for July 6, 2026, presenting a limited window for potential participants to act.

The Role of DJS Law Group

DJS Law Group specializes in securities class actions and aims to enhance investor returns through strategic counseling and assertive representation. The firm is noted for its proficiency in navigating complex corporate governance litigation and has earned a reputation for advocating for some of the most prominent hedge funds and asset managers globally.

By joining this case, affected investors may recover some of their losses incurred as a result of Immutep’s alleged misconduct. Moreover, the firm offers an opportunity to comprehensively evaluate the litigation claims that may serve as significant assets for investors seeking justice.

Conclusion

As this lawsuit unfolds, it signals a critical moment for shareholders of Immutep Limited and underscores the importance of transparency in the market. Investors are encouraged to contact DJS Law Group to explore their legal rights and options available in response to the reported violations. By taking proactive measures, affected shareholders stand a chance to reclaim their losses and hold Immutep accountable for its actions.

For further information or to discuss participation in the lawsuit, please contact:

David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: [email protected]